Implandata Ophthalmic Products

company

About

Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients.

  • 11 - 50

Details

Last Funding Type
Series C
Industries
Health Care,Medical,Medical Device,Wellness
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

Implandata Ophthalmic Products is an early stage, privately-held, venture capital funded medical device company based in Hannover, Germany. Implandata Ophthalmic Products is a medical device company offering a new technology for the treatment and management of glaucoma patients. It identifies an underserved area in care of glaucoma patients, creating disruptive solutions for better and more efficient glaucoma therapy, to the benefit of glaucoma patients, families, and care givers by integrating innovative medical technology with information technology.

IOP has developed a novel technology for 24 hour measurement of intraocular pressure, by which monitoring and therapy of glaucoma patients will be improved. This solution will allow a more efficient treatment and management of glaucoma patients.

Implandata Ophthalmic Products was founded on 2010.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€1.60M
Implandata Ophthalmic Products has raised a total of €1.60M in funding over 2 rounds. Their latest funding was raised on May 14, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 14, 2018 Series C 1 Detail
Aug 30, 2012 Series A €1.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Implandata Ophthalmic Products is funded by 2 investors. NKB and ERP Startfonds are the most recent investors.
Investor Name Lead Investor Funding Round
NKB Series C
ERP Startfonds Series A